Bone Health in Facioscapulohumeral Muscular Dystrophy
FSHD
1 other identifier
observational
94
2 countries
2
Brief Summary
This is a cross-sectional single visit study to determine bone health in individuals with FSHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2014
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 6, 2015
CompletedFirst Posted
Study publicly available on registry
April 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedResults Posted
Study results publicly available
November 5, 2019
CompletedNovember 5, 2019
February 1, 2019
1 year
April 6, 2015
August 23, 2017
November 3, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Bone Mineral Density in FSHD
To determine if bone mineral density is reduced in individuals with FSHD compared to normative data of individuals of the same age and gender without FSHD.The Bone Mineral Density Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean of a reference population (i.e., healthy, age and sex-matched individuals). Negative numbers indicate values lower than the reference population and positive numbers indicate values higher than the reference population
Single visit
Eligibility Criteria
The population consists of individuals with Facioscapulohumeral Muscular Dystrophy.
You may qualify if:
- Genetic diagnosis of FSHD including chromosome 4 deletion and haplotype
- Age \> 18 years
- Ability to provide written informed consent for participation in the study
- Ability to participate in the DEXA scan
You may not qualify if:
- Unwillingness or inability to comply with the requirements of this protocol (in the opinion of the PI) including, but not limited to, the presence of any condition (physical, mental or social) that precludes the participant from comfortably and safely obtaining a DEXA scan, phlebotomy, or neurological examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.lead
- Concord Hospitalcollaborator
- FSHD Global Research Foundationcollaborator
Study Sites (2)
Kennedy Krieger Institute, Johns Hopkins School of Medicine
Baltimore, Maryland, 21205, United States
Concord Hospital Neurology Department, Hospital Road, Concord NSW 2139
Sydney, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kathryn Wagner
- Organization
- Kennedy Krieger Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2015
First Posted
April 9, 2015
Study Start
July 1, 2014
Primary Completion
July 1, 2015
Study Completion
August 1, 2016
Last Updated
November 5, 2019
Results First Posted
November 5, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share